Close Menu

NEW YORK – Chembio Diagnostics announced Wednesday its DPP COVID-19 system has received Emergency Use Authorization from the US Food and Drug Administration. 

The serological point-of-care test and analyzer provides numerical readings for IgM and IgG antibody levels in 15 minutes from a finger stick drop of blood. The test works with Chembio's Micro Reader 1 and Micro Reader 2 analyzers. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.